Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitin sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions
- PMID: 3864367
Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitin sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions
Abstract
The stability and compatibility of clindamycin phosphate and ceftizoxime sodium, cefoxitin sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions were studied. Each antibiotic alone as well as each of the four two-drug combinations were examined when mixed in duplicate 100-mL glass bottles of 5% dextrose and 0.9% sodium chloride injections. Antibiotic concentration, pH, and visual appearance were recorded at the time of preparation and at 1, 4, 8, 12, 24, and 48 hours. Antibiotic concentrations were assessed with drug-specific high-performance liquid chromatographic assays. Decreases in concentration of 10% or more from the original concentration were considered to indicate instability. All the single antibiotic solutions were stable for 48 hours. Clindamycin was stable in all combinations except with ceftizoxime in 0.9% sodium chloride injection, which measured 89.3% of its original clindamycin concentration at 48 hours. All the cephalosporins mixed with clindamycin were stable for 48 hours. Clindamycin is stable for at least 48 hours when mixed with cefoxitin sodium, cefamandole nafate, or cefazolin sodium in either 5% dextrose or 0.9% sodium chloride injections and for at least 24 hours when mixed with ceftizoxime sodium in 0.9% sodium chloride injection.
Similar articles
-
Compatibility of clindamycin phosphate with cefotaxime sodium or netilmicin sulfate in small-volume admixtures.Am J Hosp Pharm. 1985 Apr;42(4):839-43. Am J Hosp Pharm. 1985. PMID: 4014236
-
Stability of cefamandole nafate and cefoxitin sodium solutions.Am J Hosp Pharm. 1981 Jun;38(6):875-9. Am J Hosp Pharm. 1981. PMID: 7246563
-
Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutions.Am J Hosp Pharm. 1986 Jul;43(7):1732-6. Am J Hosp Pharm. 1986. PMID: 3529949
-
Stability of frozen solutions of cefamandole nafate.Am J Hosp Pharm. 1980 Jan;37(1):98-101. Am J Hosp Pharm. 1980. PMID: 7361780
-
Clinical safety and tolerance of cefoxitin sodium: an overview.J Antimicrob Chemother. 1978 Jul;4(B):91-104. doi: 10.1093/jac/4.suppl_b.91. J Antimicrob Chemother. 1978. PMID: 357400 Review. No abstract available.
Cited by
-
Investigation of Drug-Polymer Compatibility Using Chemometric-Assisted UV-Spectrophotometry.Pharmaceutics. 2017 Jan 16;9(1):7. doi: 10.3390/pharmaceutics9010007. Pharmaceutics. 2017. PMID: 28275214 Free PMC article.
-
Stability of commonly used antibiotic solutions in an elastomeric infusion device.Can J Hosp Pharm. 2010 May;63(3):212-24. doi: 10.4212/cjhp.v63i3.917. Can J Hosp Pharm. 2010. PMID: 22478981 Free PMC article.
-
Prolonged Cefoxitin Infusion Using Mobile Elastomeric Infusors In Outpatients With Bone And Joint Infection.J Bone Jt Infect. 2018 Sep 7;3(4):182-186. doi: 10.7150/jbji.27718. eCollection 2018. J Bone Jt Infect. 2018. PMID: 30416941 Free PMC article.